Quick10K

⚲

SJW Group

Filings

10-Q	2020-09-30	Filed 2020-11-06
10-Q	2020-06-30	Filed 2020-08-10
10-Q	2020-03-31	Filed 2020-05-11
10-K	2019-12-31	Filed 2020-03-02
10-Q	2019-09-30	Filed 2019-11-01
10-Q	2019-06-30	Filed 2019-07-26
10-Q	2019-03-31	Filed 2019-04-26
10-K	2018-12-31	Filed 2019-02-27
10-Q	2018-09-30	Filed 2018-10-26
10-Q	2018-06-30	Filed 2018-07-27
10-Q	2018-03-31	Filed 2018-05-08
10-K	2017-12-31	Filed 2018-02-27
10-Q	2017-09-30	Filed 2017-10-30
10-Q	2017-06-30	Filed 2017-07-31
10-Q	2017-03-31	Filed 2017-05-01
10-K	2016-12-31	Filed 2017-02-28
10-Q	2016-09-30	Filed 2016-10-31
10-Q	2016-06-30	Filed 2016-08-01
10-Q	2016-03-31	Filed 2016-05-02
10-K	2015-12-31	Filed 2016-02-26
10-Q	2015-09-30	Filed 2015-11-02
10-Q	2015-06-30	Filed 2015-08-03
10-Q	2015-03-31	Filed 2015-05-05
10-K	2014-12-31	Filed 2015-02-25
10-Q	2014-09-30	Filed 2014-11-06
10-Q	2014-06-30	Filed 2014-08-06
10-Q	2014-03-31	Filed 2014-05-07
10-K	2013-12-31	Filed 2014-02-28
10-Q	2013-09-30	Filed 2013-11-06
10-Q	2013-06-30	Filed 2013-08-07
10-Q	2013-03-31	Filed 2013-05-01
10-K	2012-12-31	Filed 2013-02-28
10-Q	2012-09-30	Filed 2012-10-31
10-Q	2012-06-30	Filed 2012-08-02
10-Q	2012-03-31	Filed 2012-05-04
10-K	2011-12-31	Filed 2012-02-29
10-Q	2011-09-30	Filed 2011-11-02
10-Q	2011-06-30	Filed 2011-08-08
10-Q	2011-03-31	Filed 2011-05-06
10-K	2010-12-31	Filed 2011-03-01
10-Q	2010-09-30	Filed 2010-11-05
10-Q	2010-06-30	Filed 2010-08-06
10-Q	2010-03-31	Filed 2010-05-07
10-K	2009-12-31	Filed 2010-03-05

Reports

8-K	2020-11-04
8-K	2020-08-11
8-K	2020-08-06
8-K	2020-05-19
8-K	2020-05-04
8-K	2020-04-29
8-K	2020-02-26
8-K	2020-01-21
8-K	2019-12-31
8-K	2019-10-30
8-K	2019-10-08
8-K	2019-10-04
8-K	2019-09-27
8-K	2019-09-04
8-K	2019-07-24
8-K	2019-04-24
8-K	2019-03-28
8-K	2019-02-20
8-K	2018-12-03
8-K	2018-11-28
8-K	2018-11-26
8-K	2018-10-24
8-K	2018-08-05
8-K	2018-07-25
8-K	2018-05-30
8-K	2018-04-25
8-K	2018-03-22
8-K	2018-03-14
8-K	2018-02-21
8-K	2018-02-06
8-K	2018-01-04

SJW Group Financials

SJW Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	45	43	27	19	9	7	3	2	4	3	2	3	6	6	2	5	5	6	5	9	13	18	19	7	9	8	8	7	9	13	421	420	422	425
Accounts Receivable	15	17	13	13	15	18	12	14	18	19	14	14	17	18	15	18	18	20	16	14	17	21	16	15	20	23	17	18	22	23	19	18	24	28
Inventory
PP&E	1,071	1,087	1,112	1,135	1,160	1,191	1,216	1,239	1,263	1,288	1,314	1,341	1,368	1,392	1,413	1,436	1,462	1,492	1,524	1,565	1,602	1,643	1,666	1,698	1,730	1,769	1,792	1,822	1,858	1,897	1,936	1,963	2,005	2,040
Assets	1,000	1,013	1,039	1,042	1,055	1,075	1,087	1,099	1,130	1,150	1,110	1,124	1,147	1,210	1,269	1,278	1,296	1,323	1,341	1,356	1,399	1,454	1,443	1,436	1,471	1,512	1,458	1,464	1,500	1,537	1,956	1,959	2,004	2,022
Accounts Payable	10	7	7	11	14	18	8	11	16	12	13	11	13	12	7	12	13	18	16	19	24	22	19	21	27	31	23	22	26	27	25	23	28	28
Long-Term Debt	346	346	345	344	344	341	341	336	336	336	336	335	335	385	385	385	385	385	384	381	376	376	438	434	431	431	435	431	431	431	435	511	511	511
Liabilities	745	753	775	780	791	804	813	825	817	831	789	805	825	854	909	916	931	952	957	971	1,003	1,043	1,022	1,014	1,035	1,059	995	1,006	1,035	1,062	1,067	1,071	1,110	1,126
Stockholders' Equity	255	260	264	262	264	272	275	273	313	319	321	319	322	357	360	361	365	371	384	384	396	412	422	421	436	452	463	458	465	475	889	888	894	897


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue																												76	99	125		79	104	131
Cost of Revenue
Gross Profit
R&D
SG&A	10	10	10	11	11	11	11	11	11	11	11	9	10	11	11	11	11	12	12	12	12	12	12	13	13	13	16	12	12	13		12	13	15
Tax	4	5	2	1	4	7	4	1	5	6	2	1	3	16	6	3	4	6	11	2	11	13	8	2	12	14	20	0	4	5		2	10	3
Net Income	5	8	7	1	5	10	6	1	7	9	5	1	7	38	6	5	7	10	16	3	17	19	14	4	21	20	17	1	13	16	9	6	14	9


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		19	15	15	17	26	17	14	13	20	16	16	9	21	20	27	18	27	25	32	23	22	38	28	29	31	13	23	23	28		25	25	42
Cash Investing		-19	-23	-20	-25	-25	-35	-14	-23	-29	-29	-28	-19	-26	-25	-21	-26	-27	-36	-34	-29	-23	-35	-31	-22	-42	-18	-32	-36	-39		-34	-38	-42
Cash Financing		-3	-8	-2	-2	-4	14	-0	13	8	12	13	13	4	2	-3	8	0	10	6	10	7	6	-16	-5	10	6	8	15	15		8	16	4